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perimentally, and, more broadly, much work remains to
be done to understand the functional role that gene
expression noise potentially plays in the progression
of disease.
William J. Blake and James J. Collins





Arkin, A., Ross, J., and McAdams, H.H. (1998). Genetics 149,
1633–1648.
Becskei, A., Seraphin, B., and Serrano, L. (2001). EMBO J. 20,
2528–2535.
Blake, W.J., Kaern, M., Cantor, C.R., and Collins, J.J. (2003). Nature
422, 633–637.
Elowitz, M.B., Levine, A.J., Siggia, E.D., and Swain, P.S. (2002). Sci-
ence 297, 1183–1186.
Isaacs, F.J., Hasty, J., Cantor, C.R., and Collins, J.J. (2003). Proc.
Natl. Acad. Sci. USA 100, 7714–7719.
Kaern, M., Elston, T.C., Blake, W.J., and Collins, J.J. (2005). Nat.
Rev. Genet. 6, 451–464.
Kramer, B.P., and Fussenegger, M. (2005). Proc. Natl. Acad. Sci.
USA 102, 9517–9522.
McAdams, H.H., and Arkin, A. (1997). Proc. Natl. Acad. Sci. USA
94, 814–819.
Ozbudak, E.M., Thattai, M., Kurtser, I., Grossman, A.D., and van
Oudenaarden, A. (2002). Nat. Genet. 31, 69–73.
Raser, J.M., and O’Shea, E.K. (2004). Science 304, 1811–1814.
Weinberger, L.S., Burnett, J.C., Toettcher, J.E., Arkin, A.P., and
Schaffer, D.V. (2005). Cell 121, this issue, 169–182.DOI 10.1016/j.cell.2005.07.006
Plasmodium’s Sticky Fingers
The life cycle of the malaria parasite (Plasmodium) is
remarkably complex. Malaria parasites must engage
in highly specific and varied interactions with cell
types of both the mammalian host and the mosquito
vector. In this issue of Cell, Tolia et al. (2005) report
detailed molecular insights into an intimate interac-
tion between a malaria parasite protein and its host
cell receptor that enables the parasite to invade eryth-
rocytes.
Recognition of target host cells by the malaria parasite
is required for invasion and is a prelude to parasite
growth and multiplication in the host cell. Malaria para-
site invasion of host cells is clearly something that re-
search aims to prevent, but it is not the only source of
pathology. The species of malaria parasite that is re-
sponsible for the bulk of malaria-related human mortal-
ity, Plasmodium falciparum, is also a well-documented
exponent of the art of sequestration. During sequestra-
tion, Plasmodium-infected red blood cells bind to capil-lary endothelial cells of host tissues such that the ma-
laria parasite is effectively removed from the host circu-
lation. Sequestration may result in severe, often fatal
pathologies such as cerebral malaria.
P. falciparum possesses a repertoire of genes encod-
ing proteins that are dedicated to binding to host cell
receptors during either invasion or sequestration. These
proteins are capable of recognizing specific structures
on the surface of the target cell. Many of the host mole-
cules targeted by the malaria parasite are glycosylated.
Indeed, this pathogen seems to have developed a taste
for these host receptor-linked sugars. Plasmodium fre-
quently exploits the presence of sugars on host cell
receptors by expressing parasite-derived ligands that
specifically bind to glycosyl moieties. This realization
prompted an intense investigation to discover these
parasite ligands and to understand their interactions at
the molecular level. Such information should speed the
discovery and design of inhibitors that block invasion
or sequestration. The benefit of impairing either of these
activities is self-evident.
In their new study, Tolia et al. (2005) report the crystal
structure of the binding domains of the erythrocyte
binding antigen (EBA-175) of P. falciparum. During inva-
sion of red blood cells, this parasite protein binds to a
major erythrocyte glycoprotein called glycophorin A. In
particular, EBA-175 binds to sialic acid sugar residues,
which are distributed on O-linked tetrasaccharides as
part of the mucin domain of glycophorin A. EBA-175 is
a member of the erythrocyte binding protein (EBP) fam-
ily of related multidomain transmembrane proteins (Ad-
ams et al., 1992, 2001). Merozoites (the invasive blood
stage form of the malaria parasite) use EBPs as part of
a cascade of contact molecules involved in the multi-
protein, multistep invasion process that ultimately sees
the parasite gain access to the erythrocyte cytosol and
establish a vacuole. Furthermore, the six EBP family
members share an overall domain structure (see Figure
1 in Tolia et al. [2005]), yet each has its own target spec-
ificity and may bind to different erythrocyte receptor
molecules. For example, an EBP family member called
BAEBL binds to sialic acid residues on glycophorin C
(Lobo et al., 2003). The six EBP family members may
bind to different elements of receptors as shown using
protease- or glycosylase-treated erythrocytes (Mayer et
al., 2004; Gaur et al., 2004). Thus, the EBP family offers
the parasite alternative pathways for erythrocyte inva-
sion, increasing the likelihood of success.
EBA-175 operates in one parasite invasion pathway
that is sialic acid dependent. This parasite protein is a
potential vaccine and drug target candidate. Experi-
ments with EBA-175-specific antibodies, recombinant
glycophorin A, and certain EBA-175 regions (when pre-
sented as peptides) all prevent either erythrocyte inva-
sion or binding of recombinant EBA-175 to red blood
cells (Jakobsen et al., 1998; Narum et al., 2000). The
glycan binding domain of EBA-175 is known as Region
II (RII) and contains two Duffy binding-like (DBL) do-
mains called F1 and F2. Duffy binding domains—first
described in proteins of a malaria parasite from a dif-
ferent phylogenetic clade that includes Plasmodium vi-
vax—were shown to bind to another human erythrocyte
surface molecule, the Duffy antigen. DBL domains are
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150found not only in proteins of different species but also f
in multiple proteins within a single species (Adams et t
al., 1992, 2001). The presence of a DBL domain defines e
the ebl superfamily that includes not only the EBP pro- t
teins but also the var family. PfEMP-1, a P. falciparum
protein encoded by var, is expressed on the surface r
of infected red blood cells and is responsible for the T
sequestration-associated pathology of this parasite. c
Only one of a rapidly recombining and mutating pool of t
60 var genes is expressed by each individual parasite. M
Switching var gene expression results in clonal anti- e
genic variation of PfEMP-1, which helps the parasite to (
evade the host immune response. Thus, the structural t
resolution of the EBA-175 protein containing DBL do- n
mains and elucidation of its interaction with glycosyl t
targets by Tolia et al. (2005) is of broad importance. The t
EBA-175 structure has implications for understanding a
not only the basic biology of parasite invasion of host r
cells but also disease-associated pathology. The new
work may also contribute to prevention of invasion and t
sequestration through immunization or through the de- t
sign of small molecule inhibitors that block DBL-medi- m
ated parasite interactions with host cells. S
The new study (Tolia et al., 2005) reveals the crystal d
structure of the extracellular domain of EBA-175 in its o
pure monomeric and dimeric forms, as well as the di- w
mer structure in a complex with a sialic acid derivative t
(α-2,3-sialyl lactose). In this way, the investigators elu- t
cidate the amino acid residues of EBA-175 that are im- i
portant for the DBL monomeric structure, dimerization, a
and glycan binding. The monomeric form reveals the o
intramolecular disulphide bridges that are largely con- e
served in all DBL domains of EBPs (see Figure 1 in Tolia i
et al. [2005]). These bridges give specific structure to p
the F1 and F2 DBL domains, with each domain contain- s
ing the same novel protein fold. The F1 and F2 DBL m
domains each have two subdomains and form indepen- m
dent, largely helical structures within the RII region of m
EBA-175. These structures are brought together in the a
dimer to produce two prominent central channels that B
contain four of the six glycan binding sites. Both F1 and
F2 in the RII monomer form what the authors term β a
fingers, which are β hairpins that interact with a cavity t
in the second monomer (F2 with F1, and F1 with F2) to
m
stabilize the dimer. Dimerization also creates a more
m
hidden pocket in the top of the structure, within which
Dlie the two remaining glycan binding sites. It is not pos-
bsible for glycans to directly access this deep pocket
awithout significant perturbation of the protein structure.
mThus, the authors propose that RII dimerization occurs
taround glycophorin A (which is itself a dimer) during
emerozoite contact with the erythrocyte. Modeling studies
pindicate that the full O-glycan of glycophorin A could
bbe accommodated by the 6-glycan binding sites of the
tRII dimer. During merozoite invasion of an erythrocyte,
tthe requirement for EBA-175 dimerization should in-
mcrease the specificity of the interaction between the
sparasite and the host cell. This may provide a fail-safe
pmechanism to avoid potentially futile signaling through
the EBA-175 cytoplasmic domains, which are essential
for merozoite invasion, though not for erythrocyte en- A
gagement (Gilberger et al., 2003). Signal transduction
via EBA-175 is expected to trigger the later phases of T
cinvasion involving merozoite orientation and junctionormation between the apical end of the merozoite and
he erythrocyte. During these processes, apical organ-
lles of the merozoite associated with invasion (rhop-
ries, micronemes, and dense granules) are activated.
The authors next validated their observations of the
esolved RII structure and its interaction with glycans.
hey expressed mutant RII on the surface of cultured
ells in vitro and observed the ability of the mutant pro-
ein to bind to erythrocytes in a well-established assay.
utation of the residues involved in dimer-associated
lectrostatic contacts between monomers of EBA-175
that influenced the β finger/cavity interactions) or mu-
ation of various glycan binding sites resulted in a sig-
ificant reduction in the erythrocyte binding capacity of
he mutant recombinant EBA-175. Thus, both dimeriza-
ion and the implicated glycan binding sites of EBA-175
re important for physical engagement of the eryth-
ocyte.
The structure of the RII region of EBA-175 containing
wo DBL domains, and resolution of the interactions of
hese domains with glycans, elicits a measure of opti-
ism about the design of small molecule inhibitors.
uch inhibitors could be used to competitively block
imerization of RII or to block binding of RII to glycans
f the host cell receptor. Such small molecule inhibitors
ould ideally prevent the merozoite from initial recogni-
ion of its erythrocyte target and the orientation steps
hat enable the parasite to invade red blood cells lead-
ng to disease progression. Given that merozoites have
short half-life in the bloodstream, even small degrees
f interference may be sufficient to prevent invasion of
rythrocytes. An increased failure rate for successful
nvasion by merozoites not only may prevent disease
rogression but also may increase the supply of sub-
trate to the immune system, possibly enhancing anti-
erozoite immunity of the host. Antibodies that prevent
erozoite invasion are crucial players in the general im-
unity established in Africans experiencing long-term
nd repeated exposure to malaria infection (Cohen and
utcher, 1970).
The protein structures reported by Tolia et al. (2005)
llow the structures of DBLs, their potential dimers, and
heir complexes with host receptors to be modeled
ore accurately. Hopefully, a single molecule inhibitor
ight be derived that blocks the interactions of the
BL domains of all EBP family members, perhaps
locking their dimerization. Considering the physical
nd phylogenetic distribution of DBL domains in Plas-
odium, Tolia and coworkers have provided a crucial
emplate for the development of tools to reduce dis-
ase burden resulting from human infection with this
arasite. However, this promise may be compromised
y the sheer diversity of DBL domains and the struc-
ures to which they bind. In addition, the potential of
he parasite to rapidly evolve such structures may
ean that the design of simple molecules to inhibit
pecific DBL binding activities will remain a daunting
roblem.
cknowledgments
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